BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19760416)

  • 1. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound.
    Chen LD; Xu HX; Xie XY; Xie XH; Xu ZF; Liu GJ; Wang Z; Lin MX; Lu MD
    Eur Radiol; 2010 Mar; 20(3):743-53. PubMed ID: 19760416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Shin SK; Choi DJ; Kim JH; Kim YS; Kwon OS
    Medicine (Baltimore); 2018 Oct; 97(41):e12781. PubMed ID: 30313099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
    Bohle W; Clemens PU; Heubach T; Zoller WG
    Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
    Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
    Li F; Han J; Han F; Wang JW; Luo RZ; Li AH; Zhou JH
    AJR Am J Roentgenol; 2017 Oct; 209(4):767-774. PubMed ID: 28777653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
    Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
    Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-Enhanced Ultrasound for Differentiation Between Poorly Differentiated Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Guo HL; Zheng X; Cheng MQ; Zeng D; Huang H; Xie XY; Lu MD; Kuang M; Wang W; Xian MF; Chen LD
    J Ultrasound Med; 2022 May; 41(5):1213-1225. PubMed ID: 34423864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Degree of Contrast Washout on Contrast-Enhanced Ultrasound in Distinguishing Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma.
    Han J; Liu Y; Han F; Li Q; Yan C; Zheng W; Wang J; Guo Z; Wang J; Li A; Zhou J
    Ultrasound Med Biol; 2015 Dec; 41(12):3088-95. PubMed ID: 26386477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination.
    Xu HX; Chen LD; Liu LN; Zhang YF; Guo LH; Liu C
    Br J Radiol; 2012 Aug; 85(1016):1029-37. PubMed ID: 22374276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F
    J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
    Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.
    Ye J; Xie X; Lin Y; Liu B; Wang W; Huang X; Huang G
    Clin Radiol; 2018 Mar; 73(3):237-243. PubMed ID: 29122222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
    Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
    Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular-Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Ye J; Xie X; Liu B; Zhang X; Wang W; Huang X; Lu M; Huang G
    Ultrasound Med Biol; 2017 Nov; 43(11):2530-2536. PubMed ID: 28847498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.